Titles
- Medical devices1
- Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices): guidance for industry and Food and Drug Administration staff1
- Medical product communications that are consistent with the FDA-required labeling: questions and answers1
- Medical x-ray imaging devices conformance: guidance for industry and Food and Drug Administration staff1
- Medicare Advantage appeal outcomes and audit findings raise concerns about service and payment denials1
- Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices1
- Medicare Part B drug payments: impact of price substitutions based on 2015 average sales prices1
- Medicare Part B drug payments: impact of price substitutions based on 2016 average sales prices1
- Medicare Part D1
- Medicare advantage: CMS should use data on disenrollment and beneficiary health status to strengthen oversight : report to Congressional Requesters1
- Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees1
- Medicare market shares of mail-order diabetes test strips from October through December 20161
- Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data1
- Medicare payments for clinical diagnostic laboratory tests in 2017: year 4 of baseline data1
- Medicare program shared savings accountable care organizations have shown potential for reducing spending and improving quality1
- Medicare: CMS should evaluate providing coverage for disposable medical devices that could substitute for durable medical equipment : report to Congressional committees1
- Metal expandable biliary stents: premarket notification (510(k)) submissions : guidance for industry and Food and Drug Administration Staff1
- Methods used to enable interoperability among U.S. non-federal acute care hospitals in 20171
- Microdose radiopharmaceutical diagnostic drugs: nonclinical study recommendations1
- Migraine: developing drugs for acute treatment1